Patritumab Deruxtecan 43624-0021
Product NDC
43624-0021- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- January 4, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Patritumab Deruxtecan | 100 mg/5mL |
Packaging Options(1)
5 TRAY in 1 BOX (43624-021-01) / 120 VIAL, SINGLE-USE in 1 TRAY / 5 mL in 1 VIAL, SINGLE-USE